Armendariz Borunda; Juan

Patent Applications and Registrations

Patent applications and USPTO patent grants for Armendariz Borunda; Juan.The latest application filed is for "process for the preparation of a pharmaceutical composition containing pirfenidone in sustained-release tablet form and its application in the regression of human chronic renal failure, breast capsular contracture and hepatic fibrosis".

Company Profile

0.6.5

Armendariz Borunda; Juan - Mexico City MX
Armendariz Borunda; Juan - Mexico MX
Armendariz Borunda; Juan - Col. Prado Coapa MX
Armendariz Borunda; Juan - Prado Coapa MX

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Process for the preparation of a pharmaceutical composition containing pirfenidone in sustained-release tablet form and its application in the regression of human chronic renal failure, breast capsular contracture and hepatic fibrosis Grant 9,962,374 - Armendariz Borunda , et al. May 8, 2	2018-05-08
Pharmaceutical composition containing pirfenidone in sustained-release tablet form Grant 9,408,836 - Armendariz Borunda , et al. August 9, 2	2016-08-09
Process For The Preparation Of A Pharmaceutical Composition Containing Pirfenidone In Sustained-release Tablet Form And Its Application In The Regression Of Human Chronic Renal Failure, Breast Capsular Contracture And Hepatic Fibrosis App 20140296300 - Armendariz Borunda; Juan ; et al.	2014-10-02
Recombinant adenoviral vectors and their utility in the treatment of various types of fibrosis: hepatic, renal, pulmonary, as well as hypertrophic scars Grant 8,043,855 - Armendariz Borunda , et al. October 25, 2	2011-10-25
Recombinant adenoviral vectors and their utility in the treatment of various types of fibrosis: hepatic, renal, pulmonary, as well as hypertrophic scars Grant 7,858,368 - Armendariz Borunda , et al. December 28, 2	2010-12-28
Recombinant viral and non-viral vectors containing the human urokinase plasminogen activator gene and its utilization in the treatment of various types of hepatic, renal, pulmonary, pancreatic and cardiac fibrosis and hypertrophic scars Grant 7,807,457 - Armendariz Borunda , et al. October 5, 2	2010-10-05
Recombinant adenoviral vectors and their utility in the treatment of various types of fibrosis: hepatic, renal, pulmonary, as well as hypertrophic scars App 20050201984 - Armendariz Borunda, Juan ; et al.	2005-09-15
Recombinant adenoviral vectors and their utility in the treatment of various types of fibrosis: hepatic, renal, pulmonary, as well as hypertrophic scars App 20040156827 - Armendariz Borunda, Juan ; et al.	2004-08-12
Recombinant adenoviral vectors and their utility in the treatment of various types of fibrosis: hepatic, renal, pulmonary, as well as hypertrophic scars App 20030003077 - Armendariz Borunda, Juan ; et al.	2003-01-02

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.